tiprankstipranks
Trending News
More News >

LivaNova price target lowered to $55 from $56 at Barclays

Barclays lowered the firm’s price target on LivaNova (LIVN) to $55 from $56 and keeps an Equal Weight rating on the shares. The company reported a “robust beat” and its sales guidance was raised, the analyst tells investors in a research note. The firm says LivaNova’s Cardio and Epilepsy are on track for a solid 2025 performance.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1